(0.21%) 5 102.00 points
(0.56%) 38 596 points
(0.44%) 17 728 points
(0.34%) $79.22
(-0.39%) $2.03
(-0.09%) $2 307.60
(-0.22%) $26.77
(0.31%) $965.60
(0.01%) $0.932
(-0.05%) $10.99
(-0.07%) $0.797
(0.92%) $91.97
-3.03% $ 2.24
Live Chart Being Loaded With Signals
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay...
Stats | |
---|---|
Volumen de hoy | 101 560 |
Volumen promedio | 63 316.00 |
Capitalización de mercado | 21.13M |
EPS | $-1.810 ( 2024-03-26 ) |
Próxima fecha de ganancias | ( $-1.890 ) 2024-05-21 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.240 |
ATR14 | $0.0220 (0.98%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-22 | Baxter Timothy E | Buy | 65 000 | Common stock |
2024-02-22 | White Debra | Buy | 65 000 | Common stock |
2024-02-22 | Sparks Ronald M | Buy | 65 000 | Common stock |
2024-02-22 | Harvey Joan B | Buy | 65 000 | Common stock |
2024-02-22 | Glennon Michael J | Buy | 65 000 | Common stock |
INSIDER POWER |
---|
99.91 |
Last 94 transactions |
Buy: 11 877 994 | Sell: 5 035 719 |
Volumen Correlación
PAVmed Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PAVmed Inc Correlación - Moneda/Commodity
PAVmed Inc Finanzas
Annual | 2023 |
Ingresos: | $2.45M |
Beneficio Bruto: | $-6.90M (-281.40 %) |
EPS: | $-8.87 |
FY | 2023 |
Ingresos: | $2.45M |
Beneficio Bruto: | $-6.90M (-281.40 %) |
EPS: | $-8.87 |
FY | 2022 |
Ingresos: | $377 000 |
Beneficio Bruto: | $-3.24M (-858.62 %) |
EPS: | $-17.06 |
FY | 2021 |
Ingresos: | $500 000 |
Beneficio Bruto: | $-85 000.00 (-17.00 %) |
EPS: | $-1.070 |
Financial Reports:
No articles found.
PAVmed Inc
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico